Profile
ACHV VRTX REGN ALNY SGEN ARGX
Company Name Achieve Life Sciences, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc. Seagen Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $149.23M $100.25B $60.38B $59.29B $43.15B $40.18B
Employees 0.03K 6.10K 15.16K 2.23K 3.26K 1.60K
CEO Richard A. B. Stewart Reshma Kewalramani FASN, Leonard S. Schleifer Yvonne L. Greenstreet David R. Epstein Timothy Van Hauwermeiren EMBA,
Ratings
ACHV VRTX REGN ALNY SGEN ARGX
Quant Rating Score 2 3 4 1 3 4
Quant Rating Sell Neutral Buy Strong Sell Neutral Buy
Trading
ACHV VRTX REGN ALNY SGEN ARGX
Last Close $2.98 $391.02 $580.7 $446.51 $228.74 $712.2
High 52 $5.27 $516.74 $1184.69 $467.71 $228.74 $712.2
Low 52 $1.98 $366.54 $482.92 $224.58 $228.74 $514.23
Price vs. 52 Week High -43.45 % -24.33 % -50.98 % -4.53 % 0 % 0 %
Price vs. 52 Week Low 50.51 % 6.68 % 20.25 % 98.82 % 0 % 38.5 %
Total Return
ACHV VRTX REGN ALNY SGEN ARGX
1 Month Return 16.86 % -15.39 % 3.91 % 11.13 % 0 % 5.7 %
3 Month Return -23.59 % -12.22 % 18.37 % 45.88 % 0 % 21.83 %
6 Month Return -2.93 % -18.5 % -16.89 % 80.96 % 0 % 14.01 %
9 Month Return -31.96 % -16.04 % -23.83 % 76.48 % 0 % 15.34 %
YTD Return -15.34 % -2.9 % -18.48 % 89.75 % 0 % 15.8 %
1 Year Return -32.12 % -21.15 % -50.98 % 69.98 % 0 % 37.67 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ACHV VRTX REGN ALNY SGEN ARGX
Dividend Yield Percentage (TTM) - - 0.46 % - - -
Dividend Paid and Capex Coverage Ration (TTM) - 11.09 % 4.37 % -0.43 % -5.87 % -44.32 %
Dividend Per Share (TTM) - - 2.64 % - - -
Payout Ratio (TTM) - - 4.18 % - - -
Growth
ACHV VRTX REGN ALNY SGEN ARGX
Asset Growth 99.44 % -0.87 %
Gross Profit Growth -0.44 % 10.25 %
Revenue Growth - 11.66 %
Revenue 3 Year - 45.6 %
Revenue 5 Year - 163.93 %
Revenue 10 Year -100 % 1632.15 %
EBIT Growth -39.63 % -93.69 %
Net Income Growth -33.58 % -114.8 %
Net Income 3 Yeari Growth Per Share 69.35 % -122.89 %
Net Income 5 Yeari Growth Per Share 96.83 % -145.38 %
Net Income 10 Yeari Growth Per Share 99.96 % 33.84 %
Operating Income Growth -43.37 % -106.08 %
Operating Cash Flow Growth (CFG) -21.61 % -113.93 %
Operating 3 Year CFG 74.4 % -118.65 %
Operating 5 Year CFG 97.48 % -131.3 %
Operating 10 Year CFG 99.96 % 12.43 %
EPS Growth 17.33 % -114.8 %
EPS Diluted Growth 17.33 % -114.97 %
Book Value Per Share 992.29 % -6.59 %
Share Holder 3 Year Equity Growth Per Share -81.13 % 62.6 %
Share Holder 5 Year Equity Growth Per Share -98.51 % 168.85 %
Share Holder 10 Year Equity Growth Per Share -99.98 % 1292.6 %
Dividend Per Share Growth - -
Dividend 3 Year Growth Per Share - -
Dividend 5 Year Growth Per Share - -
Dividend 10 Year Growth Per Share - -
Debt Growth -40.48 % 116.42 %
Free Cash Flow Growth -21.51 % -124.1 %
Updated On 31 Dec 2024 31 Dec 2024
Profitability
ACHV VRTX REGN ALNY SGEN ARGX
Gross Profit Margin TTM -26.32 % 86.11 % 81.98 % 83.64 % 79.1 % 65.32 %
Return on Assets TTM -85.55 % 15.13 % 11.67 % -6.99 % -16.61 % 15.06 %
Return on Equity TTM -193.49 % 22.14 % 15.11 % -274.21 % -20.8 % 18.96 %
Return on Capital Employed TTM -99.51 % 19.72 % 11.45 % -5.52 % -21.46 % 5.04 %
Net Income Per EBT TTM 100 % 83.16 % 91.46 % 84.06 % 101.33 % 237.3 %
EBT Per Ebit TTM 100.61 % 111.48 % 123.23 % 210.66 % 98.26 % 147.38 %
EBIT Per Revenue TTM -21979.39 % 34.36 % 27.83 % -7.32 % -31.24 % 13.47 %
Cash Flow To Debt Ratio TTM -398.78 % 251.83 % 175.35 % -1.2 % -1043.73 % -175.92 %
Receivables Turnover TTM - 6.03 2.53 4.34 3.91 1.91
Payables Turnover TTM 0.14 0.43 3.54 3.93 1.97 0.88
Inventory Turnover TTM - 1.06 0.8 5.62 0.96 2.21
Fixed Asset Turnover TTM 245.16 % 431.08 % 293.64 % 355.68 % 665.41 % 5009.77 %
Asset Turnover TTM 0.39 % 47.51 % 37.19 % 53.92 % 53.41 % 31.97 %
Operating Cash Flow Per Share TTM -1.15 14.98 45.13 -0.12 -2.46 -1.07
Free Cash Flow Per Share TTM -1.15 13.63 36.58 -0.4 -2.88 -1.09
Cash Per Share TTM 159.71 % 3036 % 7107.14 % 2203.63 % 939.52 % 5536.58 %
Operating Cash Flow Sales Ratio TTM -17420.18 % 33.68 % 33.37 % -0.63 % -23.12 % -3.31 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 90.99 % 81.05 % 335.21 % 117.04 % 102.26 %
Cash Flow Coverage Ratios TTM -398.78 % 251.83 % 175.35 % -1.2 % -1043.73 % -175.92 %
Price To Free Cash Flows Ratio TTM -3.76 28.65 15.7 -1138.28 -81.26 -520.99
Price To Operating Cash Flows Ratio TTM -2.55 26.1 12.84 -3774.78 -93.1 -617.61
Price Cash Flow Ratio TTM -2.55 26.1 12.84 -3774.78 -93.1 -617.61
Income Statement (TTM)
ACHV VRTX REGN ALNY SGEN ARGX
Revenue $0B $11.02B
Gross Profit $-0B $9.49B
Gross Profit Ratio 0% 86.11%
EBITDA $-0.04B $0.49B
Net Income $-0.04B $-0.54B
EPS Diluted -1.24 -2.08
Balance Sheet (MRQ)
ACHV VRTX REGN ALNY SGEN ARGX
Long Term Debt $0.01B $1.66B
Total Liabilities $0.02B $6.12B
Total Equity $0.02B $16.41B
Total Investments $0.02B $6.65B
Total Debt $0.01B $1.75B
Total Assets $0.04B $22.53B
Cash Flow Statement (TTM)
ACHV VRTX REGN ALNY SGEN ARGX
Net Income $-0.04B $-0.54B
Inventory $0B $-0.52B
Dividends Paid $0B $0B
Operating Cash Flow $-0.03B $-0.49B
Capital Expenditure $0B $-0.3B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 41.82
AARD Aardvark Therapeutics, Inc. Common Stock 8.86
ABCL AbCellera Biologics Inc. 4.05
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 6.85
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.36
ABPWW 0.0311
ABSI Absci Corporation 2.34
ABUS Arbutus Biopharma Corporation 3.82
ABVC ABVC BioPharma, Inc. 2.73
ABVX Abivax SA American Depositary Shares 81.99
ACAD ACADIA Pharmaceuticals Inc. 25.69
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.7344
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACIU AC Immune SA 2.21
ACLX Arcellx, Inc. 69.75
ETFs With Exposure to ACHV
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.00479 233.9
VTI Vanguard Total Stock Market Index Fund 0.0002 315.99
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 140.31
IWN iShares Russell 2000 Value ETF 0.00399 173.15
IWO iShares Russell 2000 Growth ETF 0.00588 305.9
VXF Vanguard Extended Market Index Fund 0.00131 204.85
HDG ProShares Hedge Replication ETF 0.000615994 50.45
UWM ProShares Ultra Russell2000 0.00360063 43.54
VTHR Vanguard Russell 3000 Index Fund 0 283.308
IWC iShares Micro-Cap ETF 0.02054 142.095
URTY ProShares UltraPro Russell2000 0.00288106 48.28
VTWV Vanguard Russell 2000 Value Index Fund 0.00424 152.644
VTWG Vanguard Russell 2000 Growth Index Fund 0.0058 223.337
VTWO Vanguard Russell 2000 Index Fund 0.00486 94.62
DWMC AdvisorShares Dorsey Wright Micro-Cap ETF 0.36 30.95
XSU.TO iShares U.S. Small Cap Index ETF (CAD-Hedged) 0 44.58
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0.00021 107.49
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 107.47
VBAIX Vanguard Balanced Index Fund Institutional Shares 0.00013 51.18
VBIAX Vanguard Balanced Index Fund Admiral Shares 0.00013 51.17
VBINX Vanguard Balanced Index Fund Investor Shares 0 51.17
JMBS Janus Henderson Mortgage-Backed Securities ETF 0.11 44.99
JCPB JPMorgan Core Plus Bond ETF 0.00000136563 46.92
JSCP JPMorgan Short Duration Core Plus ETF 0 47.44
VTSAX Vanguard Total Stock Market Index Fund 0 153.84
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00131 155.35
VITSX Vanguard Total Stock Market Index Fund 0 153.86
DFSU Dimensional US Sustainability Core 1 ETF 0.00000331 40.97
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000185066 15.54
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00131 155.36
JPIE JPMorgan Income ETF 0 46.3
SURI Simplify Propel Opportunities ETF 5.03463 16.0599
VEMPX Vanguard Extended Market Index InstlPlus 0.00131 383.38
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.0002 288.63
RSSL Global X Funds 0.01 91.86
JPLD J P Morgan Exchange-Traded Fund Trust - Limited Duration Bond ETF 0 52.21
Unlock